Heffernan Michael Thomas sold TRVI
September 15, 2026 · Form 4 insider transaction
Heffernan Michael Thomas sold 100 shares of Trevi Therapeutics, Inc. at $15.88 per share, a transaction worth $1.6K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Disposed (sell-side)
Shares
100
Price
$15.88
Total value
$1.6K
InsiderHeffernan Michael Thomas
RoleDirector
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateSeptember 15, 2026
Filing dateSeptember 17, 2026
Shares owned after6,351
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
This exercise of stock options and subsequent sale were effected pursuant to a Rule 10b5-1 trading plan that was adopted on June 16, 2026.